R Béliard

719 total citations
24 papers, 577 citations indexed

About

R Béliard is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, R Béliard has authored 24 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in R Béliard's work include Blood groups and transfusion (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Proteoglycans and glycosaminoglycans research (5 papers). R Béliard is often cited by papers focused on Blood groups and transfusion (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Proteoglycans and glycosaminoglycans research (5 papers). R Béliard collaborates with scholars based in France, Switzerland and Australia. R Béliard's co-authors include Dominique Bourel, G Loyau, Jean Bocquet, Christophe de Romeuf, J.‐P. Pujol, Sylvie Jorieux, John Wijdenes, Jean‐Luc Teillaud, P Hervé and Pierre Bordigoni and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Experimental Cell Research.

In The Last Decade

R Béliard

23 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Béliard France 13 221 217 210 173 75 24 577
MP Bodger New Zealand 11 279 1.3× 143 0.7× 105 0.5× 155 0.9× 112 1.5× 19 552
J A Brieva Spain 15 404 1.8× 104 0.5× 90 0.4× 136 0.8× 118 1.6× 19 653
Pak C. Kwong Canada 14 373 1.7× 66 0.3× 395 1.9× 300 1.7× 55 0.7× 26 697
H Mitsui Japan 11 554 2.5× 163 0.8× 75 0.4× 243 1.4× 98 1.3× 15 798
Martin Nguyen United States 13 136 0.6× 286 1.3× 105 0.5× 272 1.6× 96 1.3× 28 741
T Nakahata Japan 13 309 1.4× 278 1.3× 38 0.2× 198 1.1× 87 1.2× 30 634
Helen Ferry United Kingdom 16 386 1.7× 136 0.6× 50 0.2× 165 1.0× 49 0.7× 27 637
Taichi Sekine Japan 15 196 0.9× 59 0.3× 87 0.4× 178 1.0× 42 0.6× 27 565
S L Wee United States 13 443 2.0× 153 0.7× 117 0.6× 143 0.8× 43 0.6× 24 887
F S Rosen United States 11 214 1.0× 112 0.5× 35 0.2× 211 1.2× 164 2.2× 16 559

Countries citing papers authored by R Béliard

Since Specialization
Citations

This map shows the geographic impact of R Béliard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Béliard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Béliard more than expected).

Fields of papers citing papers by R Béliard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Béliard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Béliard. The network helps show where R Béliard may publish in the future.

Co-authorship network of co-authors of R Béliard

This figure shows the co-authorship network connecting the top 25 collaborators of R Béliard. A scholar is included among the top collaborators of R Béliard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Béliard. R Béliard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dodelet, Vincent, et al.. (2019). La bioproduction des anticorps monoclonaux. médecine/sciences. 35(12). 1153–1159. 2 indexed citations
2.
3.
Romeuf, Christophe de, Charles‐Antoine Dutertre, Magali Le Garff‐Tavernier, et al.. (2008). Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16. British Journal of Haematology. 140(6). 635–643. 97 indexed citations
4.
Béliard, R, Tony Waegemans, Christophe de Romeuf, et al.. (2008). A human anti‐D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti‐D antibodies. British Journal of Haematology. 141(1). 109–119. 30 indexed citations
5.
Béliard, R. (2006). Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials. Transfusion Clinique et Biologique. 13(1-2). 58–64. 28 indexed citations
6.
Cortey, A., Y. Brossard, R Béliard, & Dominique Bourel. (2006). [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].. PubMed. 35(1 Suppl). 1S119–1S122. 4 indexed citations
7.
Sibéril, Sophie, Christophe de Romeuf, Nicolas Bihoreau, et al.. (2005). Selection of a human anti-RhD monoclonal antibody for therapeutic use: Impact of IgG glycosylation on activating and inhibitory FcγR functions. Clinical Immunology. 118(2-3). 170–179. 65 indexed citations
8.
Kumpel, Belinda M., R Béliard, Y. Brossard, et al.. (2002). Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator’s report. Transfusion Clinique et Biologique. 9(1). 45–53. 22 indexed citations
9.
Cointe, Denis, R Béliard, Sylvie Jorieux, et al.. (2000). Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties. Glycobiology. 10(5). 511–519. 28 indexed citations
10.
Béliard, R, et al.. (1997). Human recombinant anti-Rh(D) monoclonal antibodies: Improvement of biological properties by in vitro class-switch. Human Antibodies. 8(1). 17–25. 5 indexed citations
11.
Béliard, R, et al.. (1996). Use of the DAF Assay to Assess the Functional Properties of Polyclonal and Monoclonal Rh D Antibodies. Vox Sanguinis. 71(1). 30–36. 11 indexed citations
12.
Béliard, R, et al.. (1996). Anti-Rh(D) monoclonal antibodies: Study of their in vitro functional properties. Transfusion Clinique et Biologique. 3(6). 465–468. 2 indexed citations
13.
Béliard, R, et al.. (1994). Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies. Immunology Letters. 41(2-3). 139–145. 2 indexed citations
14.
15.
Wijdenes, John, et al.. (1990). A semi-pharmaceutical approach for the preparation of an anti-IL2 receptor monoclonal antibody in the treatment of acute GvHD in a multicentric study.. PubMed. 71. 103–11. 6 indexed citations
16.
Legendre, Pascal, et al.. (1988). Calcium ionophore and phorbol myristate acetate synergistically inhibited proteoglycan biosynthesis in articular chondrocytes by prostaglandin independent mechanism. Biochemical and Biophysical Research Communications. 153(2). 690–698. 12 indexed citations
17.
Bocquet, Jean, et al.. (1986). Effect of a interleukin-I like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. Biochemical and Biophysical Research Communications. 134(2). 539–549. 25 indexed citations
18.
Bocquet, Jean, et al.. (1985). Mononuclear cell-mediated modulation of synovial cell metabolism. Experimental Cell Research. 160(1). 9–18. 25 indexed citations
19.
Pujol, J.‐P., F Arenzana-Seisdedos, Jean Bocquet, et al.. (1985). Mononuclear cell-mediated modulation of synovial cell metabolism. Experimental Cell Research. 158(1). 63–74. 11 indexed citations
20.
Pujol, J.‐P., et al.. (1984). Effect of a monocyte cell factor (MCF) on collagen production in cultured articular chondrocytes: Role of prostaglandin E2. Biochemical and Biophysical Research Communications. 119(2). 499–508. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MP Bodger Breakdown of academic impact, for papers by J A Brieva Breakdown of academic impact, for papers by Pak C. Kwong Breakdown of academic impact, for papers by H Mitsui Breakdown of academic impact, for papers by Martin Nguyen Breakdown of academic impact, for papers by T Nakahata Breakdown of academic impact, for papers by Helen Ferry Breakdown of academic impact, for papers by Taichi Sekine Breakdown of academic impact, for papers by S L Wee Breakdown of academic impact, for papers by F S Rosen
Rankless by CCL
2026